Pre-order Enquiry
Request Free Sample
Global Tofacitinib Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18541751 | Publishing Date : 14-Jun-2021 | No. of pages : 111
Detailed TOC of Global Tofacitinib Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Tofacitinib Market Overview1.1 Tofacitinib Product Overview
1.2 Tofacitinib Market Segment by Type
1.2.1 5mg*60 Tablets
1.2.2 5mg*10 Tablets
1.2.3 10mg*10 Tablets
1.2.4 5mg*30 Tablets
1.2.5 5mg*14 Tablets
1.2.6 10mg*14 Tablets
1.3 Global Tofacitinib Market Size by Type
1.3.1 Global Tofacitinib Market Size Overview by Type (2016-2027)
1.3.2 Global Tofacitinib Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Tofacitinib Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Tofacitinib Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Tofacitinib Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Tofacitinib Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Tofacitinib Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Tofacitinib Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Tofacitinib Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tofacitinib Sales Breakdown by Type (2016-2021)
1.4.2 Europe Tofacitinib Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Tofacitinib Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Tofacitinib Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Tofacitinib Sales Breakdown by Type (2016-2021)
2 Global Tofacitinib Market Competition by Company
2.1 Global Top Players by Tofacitinib Sales (2016-2021)
2.2 Global Top Players by Tofacitinib Revenue (2016-2021)
2.3 Global Top Players Tofacitinib Price (2016-2021)
2.4 Global Top Manufacturers Tofacitinib Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tofacitinib Market Competitive Situation and Trends
2.5.1 Tofacitinib Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Tofacitinib Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tofacitinib as of 2020)
2.7 Date of Key Manufacturers Enter into Tofacitinib Market
2.8 Key Manufacturers Tofacitinib Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tofacitinib Status and Outlook by Region
3.1 Global Tofacitinib Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Tofacitinib Historic Market Size by Region
3.2.1 Global Tofacitinib Sales in Volume by Region (2016-2021)
3.2.2 Global Tofacitinib Sales in Value by Region (2016-2021)
3.2.3 Global Tofacitinib Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Tofacitinib Forecasted Market Size by Region
3.3.1 Global Tofacitinib Sales in Volume by Region (2022-2027)
3.3.2 Global Tofacitinib Sales in Value by Region (2022-2027)
3.3.3 Global Tofacitinib Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Tofacitinib by Application
4.1 Tofacitinib Market Segment by Application
4.1.1 Rheumatoid Arthritis
4.1.2 Ulcerative Colitis
4.1.3 Psoriasis
4.1.4 Other
4.2 Global Tofacitinib Market Size by Application
4.2.1 Global Tofacitinib Market Size Overview by Application (2016-2027)
4.2.2 Global Tofacitinib Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Tofacitinib Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Tofacitinib Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Tofacitinib Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Tofacitinib Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Tofacitinib Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Tofacitinib Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Tofacitinib Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tofacitinib Sales Breakdown by Application (2016-2021)
4.3.2 Europe Tofacitinib Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Tofacitinib Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Tofacitinib Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Tofacitinib Sales Breakdown by Application (2016-2021)
5 North America Tofacitinib by Country
5.1 North America Tofacitinib Historic Market Size by Country
5.1.1 North America Tofacitinib Sales in Volume by Country (2016-2021)
5.1.2 North America Tofacitinib Sales in Value by Country (2016-2021)
5.2 North America Tofacitinib Forecasted Market Size by Country
5.2.1 North America Tofacitinib Sales in Volume by Country (2022-2027)
5.2.2 North America Tofacitinib Sales in Value by Country (2022-2027)
6 Europe Tofacitinib by Country
6.1 Europe Tofacitinib Historic Market Size by Country
6.1.1 Europe Tofacitinib Sales in Volume by Country (2016-2021)
6.1.2 Europe Tofacitinib Sales in Value by Country (2016-2021)
6.2 Europe Tofacitinib Forecasted Market Size by Country
6.2.1 Europe Tofacitinib Sales in Volume by Country (2022-2027)
6.2.2 Europe Tofacitinib Sales in Value by Country (2022-2027)
7 Asia-Pacific Tofacitinib by Region
7.1 Asia-Pacific Tofacitinib Historic Market Size by Region
7.1.1 Asia-Pacific Tofacitinib Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Tofacitinib Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Tofacitinib Forecasted Market Size by Region
7.2.1 Asia-Pacific Tofacitinib Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Tofacitinib Sales in Value by Region (2022-2027)
8 Latin America Tofacitinib by Country
8.1 Latin America Tofacitinib Historic Market Size by Country
8.1.1 Latin America Tofacitinib Sales in Volume by Country (2016-2021)
8.1.2 Latin America Tofacitinib Sales in Value by Country (2016-2021)
8.2 Latin America Tofacitinib Forecasted Market Size by Country
8.2.1 Latin America Tofacitinib Sales in Volume by Country (2022-2027)
8.2.2 Latin America Tofacitinib Sales in Value by Country (2022-2027)
9 Middle East and Africa Tofacitinib by Country
9.1 Middle East and Africa Tofacitinib Historic Market Size by Country
9.1.1 Middle East and Africa Tofacitinib Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Tofacitinib Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Tofacitinib Forecasted Market Size by Country
9.2.1 Middle East and Africa Tofacitinib Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Tofacitinib Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Tofacitinib Business
10.1 Pfizer
10.1.1 Pfizer Corporation Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Tofacitinib Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Pfizer Tofacitinib Products Offered
10.1.5 Pfizer Recent Development
10.2 Globe Pharmaceuticals
10.2.1 Globe Pharmaceuticals Corporation Information
10.2.2 Globe Pharmaceuticals Introduction and Business Overview
10.2.3 Globe Pharmaceuticals Tofacitinib Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Pfizer Tofacitinib Products Offered
10.2.5 Globe Pharmaceuticals Recent Development
10.3 Delta Pharma Limited
10.3.1 Delta Pharma Limited Corporation Information
10.3.2 Delta Pharma Limited Introduction and Business Overview
10.3.3 Delta Pharma Limited Tofacitinib Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Delta Pharma Limited Tofacitinib Products Offered
10.3.5 Delta Pharma Limited Recent Development
10.4 Beacon Pharmaceuticals
10.4.1 Beacon Pharmaceuticals Corporation Information
10.4.2 Beacon Pharmaceuticals Introduction and Business Overview
10.4.3 Beacon Pharmaceuticals Tofacitinib Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Beacon Pharmaceuticals Tofacitinib Products Offered
10.4.5 Beacon Pharmaceuticals Recent Development
10.5 Drug International
10.5.1 Drug International Corporation Information
10.5.2 Drug International Introduction and Business Overview
10.5.3 Drug International Tofacitinib Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Drug International Tofacitinib Products Offered
10.5.5 Drug International Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tofacitinib Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tofacitinib Industrial Chain Analysis
11.4 Tofacitinib Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tofacitinib Distributors
12.3 Tofacitinib Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Tofacitinib Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of 5mg*60 Tablets
Table 2. Major Company of 5mg*10 Tablets
Table 3. Major Company of 10mg*10 Tablets
Table 4. Major Company of 5mg*30 Tablets
Table 5. Major Company of 5mg*14 Tablets
Table 6. Major Company of 10mg*14 Tablets
Table 7. Global Tofacitinib Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Tofacitinib Sales by Type (2016-2021) & (K Pcs)
Table 9. Global Tofacitinib Sales Market Share in Volume by Type (2016-2021)
Table 10. Global Tofacitinib Sales by Type (2016-2021) & (US& Million)
Table 11. Global Tofacitinib Market Share in Value by Type (2016-2021)
Table 12. Global Tofacitinib Price by Type (2016-2021) & (USD/Pcs)
Table 13. Global Tofacitinib Sales by Type (2022-2027) & (K Pcs)
Table 14. Global Tofacitinib Sales Market Share in Volume by Type (2022-2027)
Table 15. Global Tofacitinib Sales by Type (2022-2027) & (US$ Million)
Table 16. Global Tofacitinib Sales Market Share in Value by Type (2022-2027)
Table 17. Global Tofacitinib Price by Type (2022-2027) & (USD/Pcs)
Table 18. North America Tofacitinib Sales by Type (2016-2021) & (K Pcs)
Table 19. North America Tofacitinib Sales by Type (2016-2021) & (US$ Million)
Table 20. Europe Tofacitinib Sales (K Pcs) by Type (2016-2021)
Table 21. Europe Tofacitinib Sales by Type (2016-2021) & (US$ Million)
Table 22. Asia-Pacific Tofacitinib Sales (K Pcs) by Type (2016-2021)
Table 23. Asia-Pacific Tofacitinib Sales by Type (2016-2021) & (US$ Million)
Table 24. Latin America Tofacitinib Sales (K Pcs) by Type (2016-2021)
Table 25. Latin America Tofacitinib Sales by Type (2016-2021) & (US$ Million)
Table 26. Middle East and Africa Tofacitinib Sales (K Pcs) by Type (2016-2021)
Table 27. Middle East and Africa Tofacitinib Sales by Type (2016-2021) & (US$ Million)
Table 28. Global Tofacitinib Sales by Company (2016-2021) & (K Pcs)
Table 29. Global Tofacitinib Sales Share by Company (2016-2021)
Table 30. Global Tofacitinib Revenue by Company (2016-2021) & (US$ Million)
Table 31. Global Tofacitinib Revenue Share by Company (2016-2021)
Table 32. Global Market Tofacitinib Price by Company (2016-2021) & (USD/Pcs)
Table 33. Global Tofacitinib Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Tofacitinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tofacitinib as of 2020
Table 36. Date of Key Manufacturers Enter into Tofacitinib Market
Table 37. Key Manufacturers Tofacitinib Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Tofacitinib Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 40. Global Tofacitinib Sales by Region (2016-2021) & (K Pcs)
Table 41. Global Tofacitinib Sales Market Share in Volume by Region (2016-2021)
Table 42. Global Tofacitinib Sales by Region (2016-2021) & (US$ Million)
Table 43. Global Tofacitinib Sales Market Share in Value by Region (2016-2021)
Table 44. Global Tofacitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 45. Global Tofacitinib Sales by Region (2022-2027) & (K Pcs)
Table 46. Global Tofacitinib Sales Market Share in Volume by Region (2022-2027)
Table 47. Global Tofacitinib Sales by Region (2022-2027) & (US$ Million)
Table 48. Global Tofacitinib Sales Market Share in Value by Region (2022-2027)
Table 49. Global Tofacitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027)
Table 50. Global Tofacitinib Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 51. Global Tofacitinib Sales by Application (2016-2021) & (K Pcs)
Table 52. Global Tofacitinib Sales Market Share in Volume by Application (2016-2021)
Table 53. Global Tofacitinib Sales by Application (2016-2021) & (US$ Million)
Table 54. Global Tofacitinib Sales Market Share in Value by Application (2016-2021)
Table 55. Global Tofacitinib Price by Application (2016-2021) & (USD/Pcs)
Table 56. Global Tofacitinib Sales by Application (2022-2027) & (K Pcs)
Table 57. Global Tofacitinib Sales Market Share in Volume by Application (2022-2027)
Table 58. Global Tofacitinib Sales by Application (2022-2027) & (US$ Million)
Table 59. Global Tofacitinib Sales Market Share in Value by Application (2022-2027)
Table 60. Global Tofacitinib Price by Application (2022-2027) & (USD/Pcs)
Table 61. North America Tofacitinib Sales by Application (2016-2021) (K Pcs)
Table 62. North America Tofacitinib Sales by Application (2016-2021) & (US$ Million)
Table 63. North America Tofacitinib Sales Market Share in Value by Application in 2020
Table 64. Europe Tofacitinib Sales by Application (2016-2021) (K Pcs)
Table 65. Europe Tofacitinib Sales by Application (2016-2021) & (US$ Million)
Table 66. Europe Tofacitinib Sales Market Share in Value by Application in 2020
Table 67. Asia-Pacific Tofacitinib Sales by Application (2016-2021) (K Pcs)
Table 68. Asia-Pacific Tofacitinib Sales by Application (2016-2021) & (US$ Million)
Table 69. Asia-Pacific Tofacitinib Sales Market Share in Value by Application in 2020
Table 70. Latin America Tofacitinib Sales by Application (2016-2021) (K Pcs)
Table 71. Latin America Tofacitinib Sales by Application (2016-2021) & (US$ Million)
Table 72. Latin America Tofacitinib Sales Market Share in Value by Application in 2020
Table 73. Middle East and Africa Tofacitinib Sales by Application (2016-2021) (K Pcs)
Table 74. Middle East and Africa Tofacitinib Sales by Application (2016-2021) & (US$ Million)
Table 75. Middle East and Africa Tofacitinib Sales Market Share in Value by Application in 2020
Table 76. North America Tofacitinib Sales by Country (2016-2021) & (K Pcs)
Table 77. North America Tofacitinib Sales Market Share in Volume by Country (2016-2021)
Table 78. North America Tofacitinib Sales by Country (2016-2021) & (US$ Million)
Table 79. North America Tofacitinib Sales Market Share in Value by Country (2016-2021)
Table 80. North America Tofacitinib Sales by Country (2022-2027) & (K Pcs)
Table 81. North America Tofacitinib Sales Market Share in Volume by Country (2022-2027)
Table 82. North America Tofacitinib Sales by Country (2022-2027) & (US$ Million)
Table 83. North America Tofacitinib Sales Market Share in Value by Country (2022-2027)
Table 84. Europe Tofacitinib Sales by Country (2016-2021) & (K Pcs)
Table 85. Europe Tofacitinib Sales Market Share in Volume by Country (2016-2021)
Table 86. Europe Tofacitinib Sales by Country (2016-2021) & (US$ Million)
Table 87. Europe Tofacitinib Sales Market Share in Value by Country (2016-2021)
Table 88. Europe Tofacitinib Sales by Country (2022-2027) & (K Pcs)
Table 89. Europe Tofacitinib Sales Market Share in Volume by Country (2022-2027)
Table 90. Europe Tofacitinib Sales by Country (2022-2027) & (US$ Million)
Table 91. Europe Tofacitinib Sales Market Share in Value by Country (2022-2027)
Table 92. Asia-Pacific Tofacitinib Sales by Region (2016-2021) & (K Pcs)
Table 93. Asia-Pacific Tofacitinib Sales Market Share in Volume by Region (2016-2021)
Table 94. Asia-Pacific Tofacitinib Sales by Region (2016-2021) & (US$ Million)
Table 95. Asia-Pacific Tofacitinib Sales Market Share in Value by Region (2016-2021)
Table 96. Asia-Pacific Tofacitinib Sales by Region (2022-2027) & (K Pcs)
Table 97. Asia-Pacific Tofacitinib Sales Market Share in Volume by Region (2022-2027)
Table 98. Asia-Pacific Tofacitinib Sales by Region (2022-2027) & (US$ Million)
Table 99. Asia-Pacific Tofacitinib Sales Market Share in Value by Region (2022-2027)
Table 100. Latin America Tofacitinib Sales by Country (2016-2021) & (K Pcs)
Table 101. Latin America Tofacitinib Sales Market Share in Volume by Country (2016-2021)
Table 102. Latin America Tofacitinib Sales by Country (2016-2021) & (US$ Million)
Table 103. Latin America Tofacitinib Sales Market Share in Value by Country (2016-2021)
Table 104. Latin America Tofacitinib Sales by Country (2022-2027) & (K Pcs)
Table 105. Latin America Tofacitinib Sales Market Share in Volume by Country (2022-2027)
Table 106. Latin America Tofacitinib Sales by Country (2022-2027) & (US$ Million)
Table 107. Latin America Tofacitinib Sales Market Share in Value by Country (2022-2027)
Table 108. Middle East and Africa Tofacitinib Sales by Country (2016-2021) & (K Pcs)
Table 109. Middle East and Africa Tofacitinib Sales Market Share in Volume by Country (2016-2021)
Table 110. Middle East and Africa Tofacitinib Sales by Country (2016-2021) & (US$ Million)
Table 111. Middle East and Africa Tofacitinib Sales Market Share in Value by Country (2016-2021)
Table 112. Middle East and Africa Tofacitinib Sales by Country (2022-2027) & (K Pcs)
Table 113. Middle East and Africa Tofacitinib Sales Market Share in Volume by Country (2022-2027)
Table 114. Middle East and Africa Tofacitinib Sales by Country (2022-2027) & (US$ Million)
Table 115. Middle East and Africa Tofacitinib Sales Market Share in Value by Country (2022-2027)
Table 116. Pfizer Corporation Information
Table 117. Pfizer Introduction and Business Overview
Table 118. Pfizer Tofacitinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 119. Pfizer Tofacitinib Product
Table 120. Pfizer Recent Development
Table 121. Globe Pharmaceuticals Corporation Information
Table 122. Globe Pharmaceuticals Introduction and Business Overview
Table 123. Globe Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 124. Globe Pharmaceuticals Tofacitinib Product
Table 125. Globe Pharmaceuticals Recent Development
Table 126. Delta Pharma Limited Corporation Information
Table 127. Delta Pharma Limited Introduction and Business Overview
Table 128. Delta Pharma Limited Tofacitinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 129. Delta Pharma Limited Tofacitinib Product
Table 130. Delta Pharma Limited Recent Development
Table 131. Beacon Pharmaceuticals Corporation Information
Table 132. Beacon Pharmaceuticals Introduction and Business Overview
Table 133. Beacon Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 134. Beacon Pharmaceuticals Tofacitinib Product
Table 135. Beacon Pharmaceuticals Recent Development
Table 136. Drug International Corporation Information
Table 137. Drug International Introduction and Business Overview
Table 138. Drug International Tofacitinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 139. Drug International Tofacitinib Product
Table 140. Drug International Recent Development
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Tofacitinib Market Trends
Table 144. Tofacitinib Market Drivers
Table 145. Tofacitinib Market Challenges
Table 146. Tofacitinib Market Restraints
Table 147. Tofacitinib Distributors List
Table 148. Tofacitinib Downstream Customers
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Tofacitinib Product Picture
Figure 2. Global Tofacitinib Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Tofacitinib Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Tofacitinib Sales Status and Outlook (2016-2027) & (K Pcs)
Figure 5. Product Picture of 5mg*60 Tablets
Figure 6. Global 5mg*60 Tablets Sales YoY Growth (2016-2021) & (K Pcs)
Figure 7. Product Picture of 5mg*10 Tablets
Figure 8. Global 5mg*10 Tablets Sales YoY Growth (2016-2021) & (K Pcs)
Figure 9. Product Picture of 10mg*10 Tablets
Figure 10. Global 10mg*10 Tablets Sales YoY Growth (2016-2021) & (K Pcs)
Figure 11. Product Picture of 5mg*30 Tablets
Figure 12. Global 5mg*30 Tablets Sales YoY Growth (2016-2021) & (K Pcs)
Figure 13. Product Picture of 5mg*14 Tablets
Figure 14. Global 5mg*14 Tablets Sales YoY Growth (2016-2021) & (K Pcs)
Figure 15. Product Picture of 10mg*14 Tablets
Figure 16. Global 10mg*14 Tablets Sales YoY Growth (2016-2021) & (K Pcs)
Figure 17. Global Tofacitinib Sales by Type (2016-2027) & (US$ Million)
Figure 18. Global Tofacitinib Sales Market Share in Volume by Type (2016-2021)
Figure 19. Global Tofacitinib Sales Market Share in Value by Type (2016-2021)
Figure 20. Global Tofacitinib Sales Market Share in Volume by Type (2022-2027)
Figure 21. Global Tofacitinib Sales Market Share in Value by Type (2022-2027)
Figure 22. North America Tofacitinib Sales Market Share in Volume by Type in 2020
Figure 23. North America Tofacitinib Sales Market Share in Value by Type in 2020
Figure 24. Europe Tofacitinib Sales Market Share in Volume by Type in 2020
Figure 25. Europe Tofacitinib Sales Market Share in Value by Type in 2020
Figure 26. Asia-Pacific Tofacitinib Sales Market Share in Volume by Type in 2020
Figure 27. Asia-Pacific Tofacitinib Sales Market Share in Value by Type in 2020
Figure 28. Latin America Tofacitinib Sales Market Share in Volume by Type in 2020
Figure 29. Latin America Tofacitinib Sales Market Share in Value by Type in 2020
Figure 30. Middle East and Africa Tofacitinib Sales Market Share in Volume by Type in 2020
Figure 31. Middle East and Africa Tofacitinib Sales Market Share in Value by Type in 2020
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Tofacitinib Sales in 2020
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Tofacitinib Revenue in 2020
Figure 34. Tofacitinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 35. Product Picture of Rheumatoid Arthritis
Figure 36. Global Rheumatoid Arthritis Sales YoY Growth (2016-2027) & (K Pcs)
Figure 37. Product Picture of Ulcerative Colitis
Figure 38. Global Ulcerative Colitis Sales YoY Growth (2016-2027) & (K Pcs)
Figure 39. Product Picture of Psoriasis
Figure 40. Global Psoriasis Sales YoY Growth (2016-2027) & (K Pcs)
Figure 41. Product Picture of Other
Figure 42. Global Other Sales YoY Growth (2016-2027) & (K Pcs)
Figure 43. Global Tofacitinib Sales by Application (2016-2027) & (US$ Million)
Figure 44. Global Tofacitinib Sales Market Share in Volume by Application (2016-2021)
Figure 45. Global Tofacitinib Sales Market Share in Value by Application (2016-2021)
Figure 46. Global Tofacitinib Sales Market Share in Volume by Application (2022-2027)
Figure 47. North America Tofacitinib Sales Market Share in Volume by Application in 2020
Figure 48. Latin America Tofacitinib Sales Market Share in Value by Application in 2020
Figure 49. Middle East and Africa Tofacitinib Sales Market Share in Value by Application in 2020
Figure 50. Key Raw Materials Price
Figure 51. Tofacitinib Manufacturing Cost Structure
Figure 52. Tofacitinib Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Keyplayers in Global Tofacitinib Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
PfizerGlobe Pharmaceuticals
Delta Pharma Limited
Beacon Pharmaceuticals
Drug International
Request Sample
Request Discount
